Yuekang Pharmaceutical Group

Yuekang Pharmaceutical Group is a comprehensive pharmaceutical enterprise based in Beijing, China, that integrates R&D, manufacturing, and sales. Listed on the Shanghai Stock Exchange STAR Market, the company has established a robust product portfolio focusing on cardiovascular and cerebrovascular diseases, anti-infectives, and digestive health. Yuekang is notably advancing its innovation pipeline through dedicated platforms for mRNA vaccines and siRNA therapeutics, positioning itself at the forefront of genetic medicine in China. Its manufacturing infrastructure is extensive, featuring multiple GMP-certified facilities that produce a wide array of dosage forms including injections, tablets, and capsules. The company's strategic focus combines the stability of its established commercial products with high-growth potential in cutting-edge biotechnologies.